An oral androgen receptor PROTAC degrader for prostate cancer von Neklesa, Taavi K, Snyder, Lawrence B, Bookbinder, Mark, Chen, Xin, Crew, Andrew P, Crews, Craig M, Dong, Hanqing, Gordon, Deborah A, Raina, Kanak, Rossi, AnnMarie K, Taylor, Ian, Vitale, Nicholas, Wang, Jing, Willard, Ryan R, Zimmermann, Kurt

Volltext

ARV-330: Androgen receptor PROTAC degrader for prostate cancer von Neklesa, Taavi K, Jin, Meizhong, Crew, Andrew P, Rossi, AnnMarie K, Willard, Ryan R, Dong, Hanqing, Siu, Kam, Wang, Jing, Gordon, Deborah A, Chen, Xin, Ferraro, Caterina, Crews, Craig M, Coleman, Kevin, Winkler, James D.

Volltext

Abstract LB-097: Targeted degradation of the androgen receptor in prostate cancer von Jin, Meizhong, Winkler, James D., Coleman, Kevin, Crew, Andrew P., Rossi, AnnMarie K., Willard, Ryan R., Dong, Hanqing, Siu, Kam, Wang, Jing, Gordon, Deborah A., Chen, Xin, Ferraro, Caterina, Crews, Craig M., Neklesa, Taavi K.

Volltext

Abstract PR08: ARV-330: An androgen receptor PROTAC degrader for prostate cancer von Winkler, James D., Jin, Meizhong, Crew, Andy P., Rossi, AnnMarie K., Willard, Ryan R., Dong, Hanqing, Siu, Kam, Wang, Jing, Gordon, Deborah A., Chen, Xin, Ferraro, Caterina, Crews, Craig M., Coleman, Kevin, Neklesa, Taavi K.

Volltext

Abstract 5637: An oral Androgen Receptor PROTAC degrader for prostate cancer von Neklesa, Taavi K., Snyder, Lawrence B., Bookbinder, Mark, Chen, Xin, Crew, Andrew P., Crews, Craig M., Dong, Hanqing, Gordon, Deborah, Macaluso, Jennifer, Raina, Kanak, Rossi, AnnMarie, Taylor, Ian, Vitale, Nicholas, Wang, Jing, Willard, Ryan R., Zimmermann, Kurt

Volltext